Alle Insider-Transaktionen auf den wichtigsten Aktienmärkten
| 30 Tage | Letzte 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | 30% | 8.2% | 15.1% |
| Erfolgsquote | 65% | 68% | 82% |
| Transaktionen |
19
74% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Chief Executive Officer, Director | Relmada Therapeutics Inc | 29. Juli 2019 - |
| Chief Executive Officer, Interim Chief Financial Officer, Principal Financial and Accounting Officer, Director | Relmada Therapeutics Inc | 16. Februar 2017 - 29. Juli 2019 |
| Independent Director | Actinium Pharmaceuticals Inc | 1. August 2012 - 6. Juni 2017 |
| Chief Executive Officer, Director | Relmada Therapeutics Inc | 20. Mai 2014 - 16. Februar 2017 |